AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 40 filers reported holding AIM IMMUNOTECH INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $64,515 | -20.9% | 173,103 | 0.0% | 0.00% | – |
| Q1 2024 | $81,532 | +7.1% | 173,103 | 0.0% | 0.00% | – |
| Q4 2023 | $76,148 | -3.3% | 173,103 | 0.0% | 0.00% | – |
| Q3 2023 | $78,762 | -32.1% | 173,103 | 0.0% | 0.00% | – |
| Q2 2023 | $115,979 | +55.8% | 173,103 | 0.0% | 0.00% | – |
| Q1 2023 | $74,434 | -31.1% | 173,103 | -50.0% | 0.00% | – |
| Q4 2022 | $107,982 | +6.9% | 346,206 | +100.0% | 0.00% | – |
| Q3 2022 | $101,000 | -25.2% | 173,103 | 0.0% | 0.00% | – |
| Q2 2022 | $135,000 | -26.2% | 173,103 | 0.0% | 0.00% | – |
| Q1 2022 | $183,000 | +23.6% | 173,103 | +7.9% | 0.00% | – |
| Q4 2021 | $148,000 | -54.3% | 160,413 | 0.0% | 0.00% | – |
| Q3 2021 | $324,000 | -6.1% | 160,413 | 0.0% | 0.00% | – |
| Q2 2021 | $345,000 | – | 160,413 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 515,124 | $393,000 | 0.29% |
| SABBY MANAGEMENT, LLC | 185,171 | $141,000 | 0.08% |
| Hudson Bay Capital Management LP | 394,900 | $301,000 | 0.01% |
| UBS Group AG | 20 | $0 | 0.00% |
| Advisor Group, Inc. | 6 | $0 | 0.00% |
| Jacobi Capital Management LLC | 8 | $0 | 0.00% |
| Realta Investment Advisors | 85 | $0 | 0.00% |
| CREDIT AGRICOLE S A | 1 | $0 | 0.00% |
| A.R.T. Advisors, LLC | 12,369 | $9,000 | 0.00% |
| BlackRock Inc. | 10,525 | $8,000 | 0.00% |